1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Healthcare Wipes Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising issues of cross-contamination and hospital acquired infections
5.1.1.2. Regulatory standards for healthcare facilities and penetration of antibacterial and disinfectant-impregnated wipes
5.1.2. Restraints
5.1.2.1. High cost of disposable wipes and concerns associated with the use of reusable healthcare wipes
5.1.3. Opportunities
5.1.3.1. Rising focus on sustainable wipes materials
5.1.3.2. Significant investments to increase production of healthcare wipes
5.1.4. Challenges
5.1.4.1. Environmental issues and adverse effects associated with healthcare wipes
5.2. Market Segmentation Analysis
5.2.1. Product: Advancements in product categories to attract customer base
5.2.2. Use: Characteristics of healthcare wipes for specific use-cases
5.2.3. Distribution Channel: Streams for effective penetration of product categories
5.2.4. End-user: Diverse applications across end-use industries to maintain hygiene & cleanliness
5.3. Market Trend Analysis
5.3.1. Ongoing R&D to produce sustainable wipes and developed healthcare infrastructure in the Americas
5.3.2. Growing focus on healthcare hygiene and sanitation to alleviate the burden of HAIs in the APAC region
5.3.3. Product innovation and well-established standards for healthcare wipes across EMEA
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
6. Healthcare Wipes Market, by Product
6.1. Introduction
6.2. Dry
6.3. Wet
7. Healthcare Wipes Market, by Use
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Healthcare Wipes Market, by Distribution Channel
8.1. Introduction
8.2. eCommerce
8.3. Pharmacies & Drugstores
8.4. Supermarkets & Hypermarkets
9. Healthcare Wipes Market, by End-user
9.1. Introduction
9.2. Ambulances & Emergency Service Vehicles
9.3. Diagnostics Centres & Pathology
9.4. Home Care
9.5. Nursing Homes & Rehabilitation Centres
9.6. Paramedics
10. Americas Healthcare Wipes Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Healthcare Wipes Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Healthcare Wipes Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Cornerstone and Kartesia acquire Ecowipes
13.3.1.2. Envoy Solutions Acquires Two Arizona-based Companies
13.3.1.3. Hospeco Brands Group Purchases Canadian-Based Innocore
13.3.1.4. Guy & O’Neill, Inc. Acquires the U.S. Wipes Operations of Albaad USA, Inc.
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. INDA Partners with EDANA to Expand the Reach of the Industry’s First Quality and Audit Program for Hygiene Product Suppliers
13.3.2.2. Neutrogena Launches Compostable Wipes
13.3.2.3. ANDRITZ To Supply Complete Line For The Production Of Biodegradable Wipes To Teknomelt, Türkiye
13.3.2.4. Tork Announces Strategic Partnership With APIC
13.3.3. New Product Launch & Enhancement
13.3.3.1. Sellars Introduces New Ultra-Low Linting Spunlace Wipers
13.3.3.2. USDA Researchers Develop Natural, Washable Antimicrobial Cleaning Wipes
13.3.3.3. Earthbath Announces New Plant-Based Ear and Eye Wipes
13.3.3.4. Lysol Pro Solutions Launches Disinfecting Wipes 800 ct. Bucket and Refill Packs
13.3.4. Investment & Funding
13.3.4.1. Ontario Invests in New Disinfectant Wipes Production Facility in Barrie
13.3.5. Award, Recognition, & Expansion
13.3.5.1. WaterWipes Are The First Baby Wipe To Be Certified As Microbiome-Friendly By Mymicrobiome
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 2XL Corporation
14.1.2. 3M Company
14.1.3. Albaad Massuot Yitzhak Ltd.
14.1.4. American Hygienics Corporation
14.1.5. Becton, Dickinson and Company
14.1.6. Beiersdorf AG
14.1.7. Cardinal Health, Inc.
14.1.8. Colgate-Palmolive Company
14.1.9. Contec, Inc.
14.1.10. Diamond Wipes International, Inc.
14.1.11. Ecolab Inc.
14.1.12. Edgewell Personal Care Company
14.1.13. Essity AB
14.1.14. GAMA Healthcare Ltd.
14.1.15. GOJO Industries, Inc.
14.1.16. Interweave Textiles Ltd.
14.1.17. Johnson & Johnson Services, Inc.
14.1.18. Kimberly-Clark Corporation
14.1.19. Kleen-Pak Products Pte Ltd.
14.1.20. Medline Industries, LP
14.1.21. Nice-Pak Products, Inc.
14.1.22. Professional Disposables International, Inc.
14.1.23. Reckitt Benckiser Group PLC
14.1.24. Rockline Industries, Inc.
14.1.25. Sellars Absorbent Materials, Inc
14.1.26. Spartan Chemical Company, Inc.
14.1.27. STERIS PLC
14.1.28. Stryker Corporation
14.1.29. The Claire Manufacturing Company
14.1.30. The Clorox Company
14.1.31. The Procter & Gamble Company
14.1.32. Tiddox Pty Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing